Mainz Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Mainz Biomed BV
MYNZ Stock  USD 0.22  0.04  15.38%   
Mainz Biomed financial statements provide useful quarterly and yearly information to potential Mainz Biomed BV investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mainz Biomed financial statements helps investors assess Mainz Biomed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mainz Biomed's valuation are summarized below:
Gross Profit
177.6 K
Market Capitalization
16.4 M
Enterprise Value Revenue
23.3113
Revenue
917.2 K
Earnings Share
(1.11)
We have found one hundred twenty available fundamental ratios for Mainz Biomed, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Mainz Biomed last-minute market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 17.9 M in 2024. Enterprise Value is likely to drop to about 18.2 M in 2024

Mainz Biomed Total Revenue

611,085

Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Mainz Biomed Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.4 M15.4 M4.3 M
Slightly volatile
Short and Long Term Debt Total4.1 M7.4 M3 M
Slightly volatile
Other Current Liabilities838.9 K1.5 M340.1 K
Slightly volatile
Total Current Liabilities9.7 M9.2 M2 M
Slightly volatile
Property Plant And Equipment Net3.2 M3 M902.5 K
Slightly volatile
Current Deferred Revenue94.1 K138.9 K43.9 K
Slightly volatile
Accounts Payable2.4 M2.3 M608.7 K
Slightly volatile
Cash7.3 M7.1 M2.8 M
Slightly volatile
Non Current Assets Total6.8 M6.4 M1.4 M
Slightly volatile
Long Term Debt1 M1 M606.4 K
Slightly volatile
Cash And Short Term Investments7.3 M7.1 M2.8 M
Slightly volatile
Net Receivables372.2 K354.5 K97.1 K
Slightly volatile
Common Stock Shares Outstanding12.1 M16.2 M11.5 M
Very volatile
Liabilities And Stockholders Equity10.4 M15.4 M4.3 M
Slightly volatile
Non Current Liabilities Total2.7 M2.9 M2.3 M
Slightly volatile
Capital Lease Obligations899.4 K1.5 M603.6 K
Slightly volatile
Other Current Assets584.6 K940.7 K225.5 K
Slightly volatile
Total Liabilities6.2 M12.2 M3.9 M
Slightly volatile
Property Plant And Equipment Gross4.1 M3.9 M1.1 M
Slightly volatile
Short and Long Term Debt5.2 M4.9 M887.3 K
Slightly volatile
Total Current Assets8.2 M9 M3.2 M
Slightly volatile
Accumulated Other Comprehensive Income11.7 M20.8 M5.7 M
Slightly volatile
Capital Stock165.9 K235.8 K125 K
Slightly volatile
Short Term Debt5.5 M5.2 M965.2 K
Slightly volatile
Common Stock165.9 K235.8 K125 K
Slightly volatile
Other Stockholder Equity28.5 M51.5 M8.8 M
Slightly volatile
Property Plant Equipment367.4 K388.4 K465 K
Slightly volatile
Non Current Liabilities Other581.6 K654.3 K712.4 K
Slightly volatile
Intangible Assets2.7 M3.1 M3.3 M
Slightly volatile

Mainz Biomed Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.1 M1 M355.7 K
Slightly volatile
Interest Expense419.9 K809.6 K276.4 K
Slightly volatile
Selling General Administrative8.9 M13.4 M3.5 M
Slightly volatile
Selling And Marketing Expenses2.2 M3.8 M924.8 K
Slightly volatile
Total Revenue611.1 K895.5 K394.8 K
Slightly volatile
Other Operating Expenses14.5 M27.5 M6 M
Slightly volatile
Research Development10.1 M9.6 M1.8 M
Slightly volatile
Cost Of Revenue406.2 K385.8 K355.8 K
Slightly volatile
Total Operating Expenses14.1 M27.2 M5.6 M
Slightly volatile
Reconciled Depreciation909.7 K866.4 K187.8 K
Slightly volatile
Income Tax Expense2 M1.9 M456.9 K
Slightly volatile

Mainz Biomed Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings268.3 K166.8 K362.8 K
Slightly volatile
Begin Period Cash Flow18 M17.1 M3.1 M
Slightly volatile
Depreciation909.7 K866.4 K187.8 K
Slightly volatile
Capital Expenditures2 M1.9 M311.6 K
Slightly volatile
Total Cash From Financing Activities10.9 M14.2 M4.3 M
Slightly volatile
End Period Cash Flow7.3 M7.1 M2.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio19.9921.0403309
Slightly volatile
Days Sales Outstanding15214469.8594
Slightly volatile
Average Payables1.7 M1.6 M614 K
Slightly volatile
Stock Based Compensation To Revenue4.254.473210.7275
Pretty Stable
Capex To Depreciation2.32.19160.5484
Slightly volatile
EV To Sales20.3621.4309312
Slightly volatile
Payables Turnover0.160.16581.3394
Slightly volatile
Sales General And Administrative To Revenue10.4614.98445.884
Slightly volatile
Research And Ddevelopement To Revenue11.2510.70982.6136
Slightly volatile
Capex To Revenue2.232.12050.3892
Slightly volatile
Cash Per Share0.460.43530.2341
Slightly volatile
Days Payables Outstanding2.3 K2.2 K600
Slightly volatile
Income Quality0.460.83430.4853
Slightly volatile
Intangibles To Total Assets0.180.20.2163
Slightly volatile
Current Ratio0.920.97221.2836
Slightly volatile
Receivables Turnover2.42.5267.974
Very volatile
Graham Number2.72.69951.6722
Slightly volatile
Capex Per Share0.120.11690.0203
Slightly volatile
Average Receivables72.4 K124.6 K62.8 K
Slightly volatile
Revenue Per Share0.04550.05510.0364
Slightly volatile
Interest Debt Per Share0.250.41720.2322
Slightly volatile
Debt To Assets0.370.38722.1296
Slightly volatile
Days Of Payables Outstanding2.3 K2.2 K600
Slightly volatile
Ebt Per Ebit1.340.98691.1176
Slightly volatile
Quick Ratio0.860.905743.8413
Pretty Stable
Net Income Per E B T1.311.151.2186
Pretty Stable
Cash Ratio0.730.76551.1064
Slightly volatile
Days Of Sales Outstanding15214469.8594
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.831.08661.0129
Pretty Stable
Fixed Asset Turnover0.280.29510.6257
Pretty Stable
Debt Ratio0.370.38722.1296
Slightly volatile
Price Sales Ratio19.9921.0403309
Slightly volatile
Asset Turnover0.05520.05810.324
Slightly volatile

Mainz Biomed Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap17.9 M18.8 M55.2 M
Pretty Stable
Enterprise Value18.2 M19.2 M56 M
Slightly volatile

Mainz Fundamental Market Drivers

Cash And Short Term Investments7.1 M

Mainz Upcoming Events

8th of April 2024
Upcoming Quarterly Report
View
21st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue138.9 K94.1 K
Total Revenue895.5 K611.1 K
Cost Of Revenue385.8 K406.2 K
Stock Based Compensation To Revenue 4.47  4.25 
Sales General And Administrative To Revenue 14.98  10.46 
Research And Ddevelopement To Revenue 10.71  11.25 
Capex To Revenue 2.12  2.23 
Revenue Per Share 0.06  0.05 
Ebit Per Revenue(29.75)(31.24)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY